temozolomide has been researched along with palbociclib in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Aoki, Y; Banerjee, A; Gupta, N; Hashizume, R; James, CD; Ozawa, T; Prados, M | 1 |
Ajamie, RT; De Dios, A; Gelbert, LM; Kulanthaivel, P; Raub, TJ; Sanchez-Martinez, C; Sawada, GA; Shannon, HE; Staton, BA; Wishart, GN | 1 |
Bao, H; Jin, H; Li, C; Li, Z; Liang, P; Wang, W; Xiong, J; Zhang, J; Zheng, H | 1 |
Alicke, B; Choniawko, L; Forrest, WF; Gould, SE; Jakubczak, M; Mayba, O; Osinska, M; Piatkowski, P; Starr, A | 1 |
Basuli, F; Doroshow, JH; Hollingshead, MG; Jacobs, PM; James, A; Kalen, JD; Riffle, LA; Sanders, C; Shi, J; Tatum, JL; Thang, L | 1 |
5 other study(ies) available for temozolomide and palbociclib
Article | Year |
---|---|
An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing.
Topics: Animals; Antineoplastic Agents; Brain Stem Neoplasms; Caspase 3; Cyclin-Dependent Kinase Inhibitor p16; Dacarbazine; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Humans; Luminescent Agents; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Piperazines; Pons; Pyridines; Retinoblastoma Protein; Temozolomide; Time Factors; Tumor Cells, Cultured; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays | 2012 |
Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft.
Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Brain; Brain Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Dacarbazine; Dogs; Female; Glioblastoma; Madin Darby Canine Kidney Cells; Male; Mice; Piperazines; Protein Kinase Inhibitors; Pyridines; Rats; Temozolomide; Xenograft Model Antitumor Assays | 2015 |
Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Cyclin-Dependent Kinase 6; Drug Resistance, Neoplasm; Drug Synergism; Female; Glioblastoma; Humans; Macrophages; Mice; Mice, Inbred NOD; Microglia; MicroRNAs; Piperazines; Pyridines; RNA, Long Noncoding; Signal Transduction; Temozolomide; Xenograft Model Antitumor Assays | 2019 |
Generalized Additive Mixed Modeling of Longitudinal Tumor Growth Reduces Bias and Improves Decision Making in Translational Oncology.
Topics: Anilides; Animals; Antineoplastic Agents, Alkylating; Bias; Decision Making; Disease Models, Animal; Female; Genes, Tumor Suppressor; Glioblastoma; Heterografts; Humans; Medical Oncology; Mice; Mice, Nude; Models, Statistical; Neoplasm Transplantation; Neoplasms; Normal Distribution; Patched-1 Receptor; Piperazines; Pyridines; Random Allocation; Statistics, Nonparametric; Temozolomide; Translational Research, Biomedical; Tumor Burden | 2020 |
3'-[
Topics: Animals; Biomarkers; Cell Line, Tumor; Dideoxynucleosides; Humans; Mice; Piperazines; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Pyridines; Temozolomide; Thymidine; Urinary Bladder Neoplasms | 2022 |